Literature DB >> 23586432

Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal.

Anita H Clayton1, Leonard R DeRogatis, Raymond C Rosen, Robert Pyke.   

Abstract

INTRODUCTION: Brotto proposes to combine female sexual desire and arousal disorders in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition. AIM: We provide evidence that the proposed criteria could potentially exclude from diagnosis or treatment a large number of women with distressing dysfunction in sexual arousal.
METHODS: Rating scale data from nontreatment validation studies of patient-reported outcome measures including almost 500 women in North America and Europe, including 49 women diagnosed with arousal disorder only, were compared with the proposed criteria. MAIN OUTCOME MEASURES: The main measures were an early version of the eDiary (an electronic diary on sexual activity) and four previously validated measures of female sexual dysfunction (FSD), the clinician-rated Sexual Interest and Desire Inventory-Female and the self-rated Female Sexual Function Index, Changes in Sexual Functioning Questionnaire, and Female Sexual Distress Scale. Results.  The women with female sexual arousal disorder (FSAD) scored as manifestly sexually dysfunctional and significantly sexually distressed. They had fewer satisfying sexual events (SSEs) vs. women with no FSD, with a lower proportion of SSEs, and significantly fewer orgasms.
CONCLUSION: Despite evidence presented that women with FSAD have clinically disordered sexual function, our data also suggest that the majority of these women with FSAD would meet none of the six proposed "A" criteria for Sexual Interest/Arousal Disorder, raising new validity and utility concerns for the proposed diagnostic classification. Suggestions are made to modify the proposed new criteria so as to include such distressed women.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 23586432     DOI: 10.1111/j.1743-6109.2012.02859.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Sexual medicine: Experts debate--should DSM-V raise the bar for female sexual dysfunction diagnosis?

Authors:  Annette Fenner
Journal:  Nat Rev Urol       Date:  2012-08-14       Impact factor: 14.432

Review 2.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

3.  Flibanserin-Stimulated Partner Grooming Reflects Brain Metabolism Changes in Female Marmosets.

Authors:  Alexander K Converse; Yves Aubert; Kelly A Allers; Bernd Sommer; David H Abbott
Journal:  J Sex Med       Date:  2015-12-04       Impact factor: 3.802

Review 4.  What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder.

Authors:  Robert Pyke; Anita Clayton
Journal:  Sex Med       Date:  2016-12-29       Impact factor: 2.491

5.  Estimating the Prevalence of Sexual Function Problems: The Impact of Morbidity Criteria.

Authors:  Kirstin R Mitchell; Kyle G Jones; Kaye Wellings; Anne M Johnson; Cynthia A Graham; Jessica Datta; Andrew J Copas; John Bancroft; Pam Sonnenberg; Wendy Macdowall; Nigel Field; Catherine H Mercer
Journal:  J Sex Res       Date:  2015-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.